PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Medicine, Hebrew University of Jerusalem, Department of Neurology and Laboratory of Neuroimmunology and the Agnes-Ginges Center for Neurogenetics, Hadassah Medical Center, Ein-Kerem, Jerusalem, Israel.\', \'Clinical Virology Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel.\', \'Lautenberg Center for General and Tumor Immunology, The Hebrew University Faculty of Medicine, Jerusalem, Israel.\', \'F. Hoffmann-La Roche Ltd, Basel, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jamaneurol.2021.3599
?:doi
?:hasPublicationType
?:journal
  • JAMA neurology
is ?:pmid of
?:pmid
?:pmid
  • 34554197
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.925
?:rankingScore_hIndex
  • 203
is ?:relation_isRelatedTo_publication of
?:title
  • Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all